254 results
8-K
EX-10.2
LFCR
Lifecore Biomedical Inc
20 Mar 24
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
6:32pm
commission of any act of fraud, embezzlement, dishonesty or any other willful misconduct that has caused or is reasonably expected to result in material
8-K
EX-10.3
LFCR
Lifecore Biomedical Inc
20 Mar 24
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
6:32pm
, fraud, defamation, and negligent or intentional infliction of emotional distress; and
(d)any and all claims for monetary or equitable relief, including
8-K
EX-10.4
1lp2 c1ja90d6vt2
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
8-K
EX-10.1
89sdzc
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
8-K
EX-10.1
q581mqnxif 8fszrukky
10 Aug 22
Landec Corporation Reports Fourth Quarter and Full Fiscal Year 2022 Results
4:20pm